Results 151 to 160 of about 5,242 (246)

HASH(0x563d44076e60) [PDF]

, 2006
Guba, B.
core  

MAPPING current decision-making pathways and reimbursement processes for high-risk medical devices in EU/EEA member states and the UK: a scoping review. [PDF]

Int J Technol Assess Health Care
Alshaikh RA, Walsh KA, El-Komy F, Spillane S, Carrigan M, Larkin L, Harrington P, O'Neill M, Teljeur C, Ryan M, O'Driscoll CM.   +10 more
europepmc   +1 more source

[Patient-centered care-aspirations and implementation in the German healthcare system]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Härter M, Scholl I, Koch-Gromus U.
europepmc   +1 more source

Identification and Description of Regulatory and Health Technology Assessment Agencies' Guidance Related to Patient Experience Data in North America, Europe, and Asia Pacific. [PDF]

Ther Innov Regul Sci
Delbecque L, Zschocke J, Ding D, Poon JL, Alonzo C, Pérez NG, Myrick S, Hill JN.   +7 more
europepmc   +1 more source

Crossing borders: the need for empirical evidence of real-world evidence transportability in oncology. [PDF]

J Comp Eff Res
Clunie-O'Connor C, Thuresson PO, Masters E, Taylor A, Rosenlund M, Mpofu P, Adamson B.   +6 more
europepmc   +1 more source

A Comparison of Additional Benefit Assessment Methods for Time-to-Event Endpoints Using Hazard Ratio Point Estimates or Confidence Interval Limits by Means of a Simulation Study. [PDF]

Med Decis Making
Büsch CA, Kirchner M, Behnisch R, Kieser M.   +3 more
europepmc   +1 more source